Work Experiences

March, 2022-December, 2022  Zhonglun Law Firm  Non-Equity Partner

May,2019-February, 2022  PacGate Law Group Partner

February,2018-April, 2019  Legal Department of JD.com Inc.  Investment Legal Director

December,2010-January, 2018  PacGate Law Group Associate/Partner

Education Background

September, 2004-June, 2008 Foreign Languages School, Central South University   Bachelor of English Language and Literature

September, 2008-July, 2011 Juris Mater, China University of Political Science and Law

September, 2009-June, 2011, LL.M (Master of European Law and International Law), University of Hamburg

Bar Admissions/Professional Qualifications

2016, Member of PRC Bar

Languages

Chinese, English

Professional Honors

ALB 2015 China Client Choice 20

2018 LEGALBANDN Rising Star of Private Equity & Venture Capital

2019 LEGALBAND China Top 10 Lawyer Special List: E-Sport

2021 LEGALBAND Client Choice 15 of Rising Partner and TMT Highly Recommended Individual

2022 DAWKINS Capital Market Client Guide-Chinese Top Lawyers List-Third Tier of Fund Formation and Compliance/New Economics

Other Professional and Social Activities

N/A

Publications

October, 2015, CHINA BUSINESS LAW JOURNAL: Practical operation involved in quasi-equity investments by private equity funds

Representative Cases

Advised JD Daojia in its merger with Dada

Advised JD in its investment in portfolios of Giga Cloud, Inceptio, Omni Prime, Weizhi, Cone Energy Robot, Zhuanglong UAV, EZR, TERMINUS Group and etc.

Advised JD in its formation of JD Logistics Fund and its investment in Sequoia Fashion Fund, Skycus Fund, Hosen Fund, CPE, Broad Vision Funds and etc.

Advised Huaxing Growth Capital for its formation of RMB Fund I, Fund II and Fund III and its formation of Feeder Funds investing in 360, BEKE and Focus Media

Advised Caogenzhiben in its formation of ORIHOPE Fund

Advised Ivision Capital in its formation of RMB Fund I and Fund II

Advised Huaxing Growth Capital in its investment in portfolios of BEKE, SenseTime, ZHIHU, HUITONGDA, Hero Entertainment, ZHANGMENG, and etc.

Advised Betta Pharma in its investment/license with Xcovery, Amgen, Agenus and West China Hospital

Advised ShiyueDaotian, Injoying, Qingyan Health, Chuangkit, Triple Life for its series of Financing